Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Adicciones ; 34(3): 208-217, 2022 Jul 01.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-33338245

RESUMO

The use of new technologies has become widespread worldwide. There is increasing concern about "Internet addiction disorder" (IAD), "Internet gaming disorder" (IGD), and "Mobile phone addiction" (MPA). Attention Deficit Hyperactivity Disorder (ADHD) has been associated with IAD and IGD. However, evidence is lacking about the relationship between ADHD and MPA. Naturalistic case-control study. 112 patients (51 children with and 61 children without ADHD) between 7 and 17 years old were compared regarding IAD, IGD, and MPA. We used the TEA questionnaire for the assessment of executive function and ADHD (ATENTO), and the ADITEC questionnaire to get gender-differentiated information for IAD, IGD, and MPA. Female children scored higher on MPA (Mean ± Standard Deviation, M ± SD) (25.93 ±  17.64 vs. 14.77 ±  19.43, p=0.03), while male children scored higher on IGD (30.09 ± 21.65 vs. 12.51 ± 16.61, p < 10^-3). Severity of hyperactivity/impulsivity and IGD were moderately correlated (r=0.349, p=0.013), but the correlation disappeared after controlling for the impact on the social domain as measured by the ATENTO questionnaire (r=171, p=0.250). Most parents are concerned that their children may be addicted to IAD/IGD/MPA. Female gender is associated with MPA, while male gender is associated with IGD. ADHD is a risk factor for developing IAD and IGD. Combined type and predominantly hyperactive/impulsive ADHD are each associated with IGD. Good social adjustment protects against developing IGD. There are gender vulnerabilities for IAD/IGD/MPA. ADHD is a risk factor for IGD, but good social adjustment buffers this association.


El uso de las nuevas tecnologías se ha generalizado a nivel mundial. Hay una creciente preocupación respecto del «trastorno de adicción a Internet¼ (TAI), el «trastorno de juego en Internet¼ (TJI) y la «adicción al teléfono móvil¼ (ATM). El trastorno por el déficit de atención con hiperactividad (TDAH) se ha asociado con el TAI y el TJI. Sin embargo, falta evidencia sobre la relación entre el TDAH y la ATM. Estudio naturalista de casos y controles. Comparación de 112 pacientes (51 niños con el TDAH y 61 niños sin el TDAH) con edades entre 7-17 años respecto del TAI, el TJI y la ATM. Utilizamos el cuestionario de TEA para evaluar la función ejecutiva y el TDAH (ATENTO) y el cuestionario ADITEC para obtener información diferenciada por género para el TAI, el TJI y la ATM. Las niñas obtuvieron puntuaciones más altas en la ATM (desviación típica ± media, DT ± M) (25,93 ± 17,64 vs. 14,77 ± 19,43, p = ,03), mientras que los niños obtuvieron puntuaciones más altas en el TJI (30,09 ± 21,65 vs. 12,51 ± 16,61, p < 10


Assuntos
Transtorno do Deficit de Atenção com Hiperatividade , Comportamento Aditivo , Telefone Celular , Jogos de Vídeo , Adolescente , Criança , Feminino , Humanos , Masculino , Transtorno do Deficit de Atenção com Hiperatividade/complicações , Transtorno do Deficit de Atenção com Hiperatividade/epidemiologia , Comportamento Aditivo/complicações , Comportamento Aditivo/diagnóstico , Comportamento Aditivo/epidemiologia , Estudos de Casos e Controles , Internet
3.
Eur J Dent Educ ; 5(3): 120-6, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11520335

RESUMO

The aim of the present study is the evaluation of a pre-clinical training system using indirect vision for dental education purposes. The study population was undergraduate dental students between the ages of 18-20, at the beginning of their first dental course. From a total of 105 students, those presenting some condition that would have had influence on their manual skills and those who for some circumstance left the study after beginning it were excluded, resulting in 69 students (51 female and 18 male) taking part in the study. The study design involved two sessions separated by a 7-day interval in which the students used a reflection box to develop psychomotor skills in mirror use. In every session they performed an initial evaluation test, some training exercises and a final evaluation test. The evaluation tests and the training exercises consisted in following a curved, straight or convoluted shape in the reflection box. Four groups of students were used who trained in different ways using curved or straight lines. Evaluation of the tests was based on the number of errors made and the time to completion. All students showed an improvement in their performance of following curved and straight lines with indirect vision after this form of training. The results after the first training session were statistically significant, while the further improvement was not significant after the 2nd training session. Those students who trained first with curved lines and later with straight lines produced more errors than the other groups. Female students performed better than male students in this assessment.


Assuntos
Educação em Odontologia , Ensino/métodos , Visão Ocular/fisiologia , Adolescente , Adulto , Análise de Variância , Feminino , Humanos , Aprendizagem , Masculino , Destreza Motora/fisiologia , Avaliação de Programas e Projetos de Saúde , Fatores Sexuais , Estatística como Assunto , Estatísticas não Paramétricas , Estudantes de Odontologia , Fatores de Tempo
4.
Orthop Clin North Am ; 27(3): 545-9, 1996 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8649735

RESUMO

The incorporation of antineoplastic agents in the treatment of pediatric musculoskeletal malignancies and their impact in the management and outcome of patients with these types of malignancies are briefly reviewed. The role of chemotherapy in the management of these tumors with special emphasis on osteosarcoma, Ewing's sarcoma family of tumors, and rhabdomyosarcoma and undifferentiated sarcomas is discussed. Also included are complications and side effects of the antineoplastic agents.


Assuntos
Neoplasias Ósseas/tratamento farmacológico , Neoplasias Musculares/tratamento farmacológico , Antineoplásicos/efeitos adversos , Criança , Humanos , Osteossarcoma/tratamento farmacológico , Rabdomiossarcoma/tratamento farmacológico , Sarcoma/tratamento farmacológico , Sarcoma de Ewing/tratamento farmacológico
5.
Orthop Clin North Am ; 27(3): 615-23, 1996 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8649742

RESUMO

Langerhans' Cell Histiocytosis, formerly known as Histiocytosis X, and its related syndromes (i.e., eosinophilic granuloma, Hand-Schuller-Christian disease, and Letterer-Siwe disease) are briefly reviewed. The biology, clinical manifestations, and treatment options of the localized, single form and the disseminated, multisystem form are also discussed.


Assuntos
Histiocitose de Células de Langerhans , Histiocitose de Células de Langerhans/diagnóstico , Histiocitose de Células de Langerhans/patologia , Histiocitose de Células de Langerhans/terapia , Humanos
6.
Invasion Metastasis ; 16(2): 83-96, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-9030243

RESUMO

A new human metastatic rhabdomyosarcoma (RMS) model was established and analyzed for a number of biologic, cytogenetic and molecular parameters. Consistent with previous studies, the metastatic capacity of different RMS cell variants did not correlate with their tumorigenic or proliferative capacities. Interestingly, a highly metastatic variant was diploid, while a nonmetastatic variant was tetraploid, which parallels previous clinical observations. Genes whose expression had been found to be associated with either low- or high-metastatic capacity in carcinoma or melanoma did not show a similar association with different metastatic variants of RMS, derived from a mesenchymal tumor. We also found, in transient reporter gene assays, that several promoters had higher transcriptional activity in highly metastatic than in nonmetastatic RMS cell variants. This novel human RMS metastatic model may be instrumental for a better understanding of the regulatory pathways that control the metastatic phenotype of tumors of mesenchymal origin.


Assuntos
Rabdomiossarcoma/patologia , Animais , Divisão Celular , Diploide , Gelatinases/metabolismo , Regulação Neoplásica da Expressão Gênica , Genes Reporter , Humanos , Metaloproteinase 2 da Matriz , Metaloendopeptidases/metabolismo , Camundongos , Camundongos Nus , Metástase Neoplásica , Proteínas de Neoplasias/metabolismo , Transplante de Neoplasias , Poliploidia , Regiões Promotoras Genéticas , Proteínas Recombinantes de Fusão/biossíntese , Rabdomiossarcoma/genética , Transfecção
7.
J Clin Endocrinol Metab ; 81(1): 93-9, 1996 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8550801

RESUMO

1 alpha,25-Dihydroxycholecalciferol [1,25-(OH)2D3] is a potent differentiating agent in a variety of tumor cell lines. However, the induction of severe hypercalcemia has limited its clinical use. Several analogs have been synthesized that retain the antiproliferative differentiating effects of 1,25-(OH)2D3, but do not have the calcitropic effect of the parent compound. One such analog, 1 alpha,25(OH)2-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), can induce differentiation in HL-60 cells and does not induce hypercalcemia in animal models. We, therefore, evaluated the effect of Ro24-5531 on a human osteosarcoma cell line, MG-63. Compared with 1,25-(OH)2D3, the analog Ro24-5531 is 10-100 times more potent as an inhibitor of MG-63 cell proliferation, as determined by [3H]thymidine incorporation and/or 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The inhibition in cell growth is accompanied by a decrease in the expression of p34cdc2 (> 4-fold), a protein critically involved in cell cycle regulation. Ro24-5531 treatment of MG-63, at a concentration of 10(-8) mol/L, induced expression of the bone differentiation markers biglycan and osteocalcin, as determined by Northern analysis. These data suggest that Ro24-5531 treatment induces growth arrest coupled with differentiation. To begin to evaluate the mechanisms by which Ro24-5531 may exert an effect, we evaluated the effect of Ro24-5531 on components of the insulin-like growth factor I (IGF-I) signaling pathway, an important regulator of normal bone growth and differentiation. The expression of IGF-binding protein (IGFBP), IGFBP-3 messenger ribonucleic acid, and protein levels are increased 20-fold after 72 h of treatment with Ro24-5531 and are associated with a marked increase in detectable binding of ligand to binding protein, as measured by RRA. These data suggest an association between Ro24-5531-induced growth arrest and increased expression of IGFBP-3.


Assuntos
Calcitriol/análogos & derivados , Diferenciação Celular/efeitos dos fármacos , Proteína 3 de Ligação a Fator de Crescimento Semelhante à Insulina/biossíntese , Osteossarcoma/patologia , Desenvolvimento Ósseo/efeitos dos fármacos , Calcitriol/farmacologia , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Humanos , Proteína 3 de Ligação a Fator de Crescimento Semelhante à Insulina/genética , Proteína 3 de Ligação a Fator de Crescimento Semelhante à Insulina/farmacologia , Fator de Crescimento Insulin-Like I/metabolismo , RNA Mensageiro/análise
8.
Cancer Res ; 54(10): 2803-7, 1994 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-8168113

RESUMO

Osteogenic sarcoma is the most common bone tumor of childhood and typically occurs during the adolescent growth spurt when growth hormone and insulin-like growth factor I (IGF-I) may be at their lifetime highest levels. Since IGF-I is involved in normal bone growth and differentiation, we have evaluated the possible role of IGF-I signaling in the growth of human osteogenic sarcoma cell lines. In this study, we demonstrate that in vitro survival of cells is dependent on exogenously supplied IGF-I. Furthermore, we show that these cells display functional IGF-I receptors on their surface and that in vitro growth is inhibited by blocking these receptors either by monoclonal antibodies or by antisense oligonucleotides. These data demonstrate that human osteogenic sarcoma cell lines are dependent on signaling through the IGF-I receptor for in vitro survival and proliferation. Furthermore, they suggest that modulation of the growth hormone/IGF-I axis may affect the growth of these tumors in vivo.


Assuntos
Fator de Crescimento Insulin-Like I/análise , Osteossarcoma/patologia , Receptor IGF Tipo 1/análise , Divisão Celular , Sobrevivência Celular , Meios de Cultura Livres de Soro , Humanos , Óleo Mineral/farmacologia , Osteossarcoma/química , RNA Mensageiro/análise , RNA Neoplásico/análise , Receptor IGF Tipo 1/efeitos dos fármacos , Receptor IGF Tipo 1/fisiologia , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA